At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Prospective Randomized Study of Duragen vs. Duraguard in Chiari Surgery
In Brief
A Phase 3 clinical trial evaluating Duragen duraplasty and Duraguard duraplasty for Chiari Malformation. Completed, enrolled 34 participants across 1 site.
Detailed Summary
The study evaluates two materials used for duraplasty of the posterior cranial fossa in treatment of Chiari malformation. One material (DuraGen) is a non-suturable collagen matrix that is applied over the defect if brain coverings (dura); the other (DuraGuard) is made out of bovine pericardium and has to be sutured during application. The study compares these two materials used for duraplasty of patients undergoing Chiari surgery in a prospective randomized fashion to check the rate of surgical complications associated with each material, patient's outcomes, length of surgery and the hospital stay, etc.
Study Details
Timeline
Interventions
Posterior cranial fossa repair and enlargement with application of dural patch (Duragen)
Posterior cranial fossa repair and enlargement with application of dural patch (Duraguard)